As of 2:38pm ET
| -0.08 / -2.04%|
The 4 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 13.88, with a high estimate of 19.00 and a low estimate of 13.00. The median estimate represents a +261.33% increase from the last price of 3.84.
The current consensus among 4 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.